We have contacted each of our clients individually, and discussed the possibility of switching their medication where appropriate.
Long term supplies of Lisdexamfetamine (Elvanse) and Atomoxetine (Strattera) remain uncertain.
As a responsible healthcare provider, we are following government guidance, which has not changed since the shortage began. This means that we are still not prescribing medication to any new clients.
We have received assurance this week that the stock levels of Methyphenidate (Concerta XL, Xenidate XL, Matoride XL, Xaggitin, Equasym XL, Medikinet XL) have stabilised.
Unfortunately, there are still supply issues with Lisdexamfetamine (Elvanse) and Atomoxetine (Strattera).
What does this mean for you or your child?
We are looking to resume prescribing medication as soon as we are able:
There is a global shortage of the following ADHD medications:
As a result, supply reliability is significantly affected. In order to maintain clinical safety, ProblemShared will be advising all clients to take a break from medication. We will not be prescribing ADHD medications until reliable provision of medication can resume.
Please be assured that every effort is being made to find a resolution. While the issue is out of our control, we will do everything we can to support you through this time.
If the medication shortage affects you or your child, you will have received email communication from us advising you on how to proceed with alternative treatment options. For further information, please read the FAQs further down this page, or download our guide to navigating the ADHD medication shortage.
Some suggested coping mechanisms from our clinical team that might help to manage your symptoms during the medication shortageDownload our guide
A pre-written letter to take to your employer to inform them of the ADHD medication shortageDownload employer letter
A pre-written letter to take to your child’s school to inform them of the ADHD medication shortageDownload school letter